Vivo Capital — Full Portfolio

Harmony Biosciences develops innovative therapeutic treatments focused on rare neurological diseases.

BiotechHealthtechMedical DevicesNorthbrook, US

JAJeffrey Aronin(Director)inJMJeffrey M. Dayno, M.D.(President and Chief Executive Officer)inPatrick Morris(Secretary and Treasurer)inRobert Repella(Director and Chief Executive Officer)Darien Parhad(Chief Financial Officer)

BoardARAaron Royston(Director)in

Board seatJNJack Nielsen· per SEC Form D

Co-investorsAIAisling CapitalHBHBM Healthcare InvestmentsHBHBM PartnersPAParagon Biosciences LLCPIPivotal Life SciencesVAValor Equity Partners+3 more

Sera Prognostics develops women's health diagnostics focused on pregnancy, including the PreTRM blood test that predicts an individual's risk of spontaneous preterm birth in singleton pregnancies and the LikeMine platform that compares pregnancy outcomes using U.S. pregnancy data.

BiotechDigital HealthFemTechHealthtechSalt Lake City, US

Douglas Fisher(Executive Officer)Jay Moyes(Executive Officer)inGregory C. Critchfield(Executive Officer, Director)inAAAndrew A. Sauter(Executive Officer)inZhenya Lindgardt(President and Chief Executive Officer)in

BoardMansoor Mirza(Director)

Board seatJoseph Siletto· per SEC Form D

Co-investorsAMaMoonEXExcelestar VenturesINIntermountain HealthOUOUP (Osage University Partners)UPUpStart VenturesCACatalyst Health Ventures+1 more

Aadi Bioscience develops therapies targeting mTOR-driven diseases using precision medicine and albumin-bound nanoparticle technology, applying genomic profiling to identify patients most likely to benefit from mTOR inhibition.

BiotechHealthtechMorristown, US

Scott Giacobello(Executive Officer)inBryan Ball(Executive Officer)DLDave Lennon(Executive Officer, Director)inDDDavid Dornan(Executive Officer)James Murphy(Executive Officer)Stephen Pakola(Executive Officer)

Co-investors3B3B Future Health FundALAlly Bridge GroupDEDecheng CapitalOROrbiMed

Achieve is a specialty pharmaceutical company developing and commercializing cytisinicline as a treatment for nicotine dependence, aimed at helping people who smoke quit.

BiotechHealthtechVancouver, B.C., US

Anthony Clarke(Executive Officer)RSRichard Stewart(Co-founder & Director (former President and CEO))CJCindy Jacobs(Executive Officer, Director)inJXJaime Xinos(Executive Officer)inJBJohn Bencich(Executive Officer, Director)inAndrew D. Goldberg(Chief Executive Officer & Director)in

Co-investorsLILifeSci Venture PartnersVEvenBio PartnersFRFrazier Life Sciences

Aclaris develops investigational monoclonal antibodies and small-molecule inhibitors targeting immune pathways for the treatment of atopic, autoimmune, and respiratory diseases.

BiotechHealthtechMedical DevicesWayne, US

Neal Walker(Executive Officer, Director)Kamil Ali-Jackson(Executive Officer)SDStuart D. Shanler(Executive Officer)inJoseph Monahan(Executive Officer)inHDHugh Davis(Executive Officer, Director)inJames Loerop(Executive Officer)

Co-investorsAIAisling CapitalAPAPERTURE Venture PartnersF-F-Prime CapitalFOForesite CapitalRARA CapitalSOSofinnova Ventures+1 more

Alto Neuroscience is a clinical-stage biopharmaceutical company developing biology-driven medicines for neuropsychiatric conditions, using measurements of brain biology to predict clinical response and identify patients likely to benefit from its drug candidates.

BiotechDigital HealthMental HealthMountain View, US

AEAmit Etkin(Founder)inASAdam Savitz(Executive Officer)inMHMichael Hanley(Executive Officer)Nicholas Smith(Chief Financial Officer and Chief Business Officer)inAaron Weaver(Director)Po Yu (Jeff) Chen(Director)

Co-investorsABAble PartnersALAlpha Wave GlobalGAGaingelsINInVivium CapitalK2K2 HealthVenturesKOKorify Capital+12 more

ALX Oncology develops therapies for cancer treatment, operating in the biotechnology and medical technology sectors.

BiotechHealthtechMedical Devices

CGCorey Goodman(Chairman)inJLJason Lettmann(Chief Executive Officer)in

Co-investorsLILightstone VenturesAGage1FOForesite CapitalHBHBM Healthcare InvestmentsHBHBM PartnersVEvenBio Partners+1 more

Bolt Biotherapeutics is a clinical-stage biotech company developing novel immunotherapies that leverage innate immune system mechanisms to treat cancer.

BiotechHealthtechMedical DevicesSan Francisco, US

DEDr. Edgar G. Engleman(Founder)

Co-investorsPFPfizer Venture InvestmentsPIPivotal Life SciencesRARA CapitalSASamsara BioCapitalSOSofinnova VenturesNANan Fung Life Sciences+3 more

Compass Pathways develops novel treatments for mental health conditions, with a focus on psychedelic-assisted therapies supported by rigorous clinical research.

BiotechDigital HealthHealthtechMedical DevicesMental Health

Kabir Nath(CEO)Ekaterina Malievskaia(Founder)George Goldsmith(Founder)

Co-investorsABAble PartnersAIAisling CapitalBABailey Venture PartnersCACatalio Capital Management, LPJAJam FundNONoetic+2 more

Compass Therapeutics uses proprietary antibody discovery platforms to generate and screen diverse panels of monoclonal and multispecific antibodies, aiming to identify synergistic therapeutic combinations.

BiotechHealthtechCambridge, US

STSchuetz Thomas(Executive Officer, Director)inEAErrik Anderson(Executive Officer, Director)inTJThomas J. Schuetz(Executive Officer, Director)inVBVered Bisker-Leib(Executive Officer)inBarry Shin(Chief Financial Officer)inNLNeil Lerner(Senior Vice President, Chief Accounting Officer)in

Co-investorsALAlumni VenturesBIBioBritF-F-Prime CapitalFOForesite CapitalGVGV (Google Ventures)OROrbiMed+3 more

Instil Bio is a biotechnology company that identifies and acquires or licenses therapeutic candidates for development, with a strategic focus on securing additional novel drug candidates targeting diseases with significant unmet medical needs.

BiotechDallas, US

Bronson Crouch(Chief Executive Officer / Chairman of the Board)inSandeep "Steve" Laumas(Chief Financial Officer & Chief Business Officer)inNSNimish Shah(Director)inGwen Binder(Director)Neil Gibson(Director)George Matcham(Director)

Co-investorsCUCurative VenturesWEWellington ManagementCPCPMGVEVenrock

Mereo BioPharma is a biopharmaceutical company publicly traded on Nasdaq under the ticker MREO.

BiotechHealthtechLondon, GB

JRJohn Richard(Head of Corporate Development and Co-Founder)inCharles Sermon(General Counsel and Co-Founder)Richard Jones(Chief Financial Officer)inJill Henrich(Senior Vice President)inDenise Scots-Knight(Chief Executive Officer)in

BoardDr. Deepa Pakianathan(Non-Executive Director)

Co-investorsCACancer FocusPOPontifax Venture CapitalWOWoodford Investment Management

Minerva Neurosciences is a clinical-stage biopharmaceutical company developing product candidates for central nervous system disorders.

BiotechHealthtechWaltham, US

Joseph Reilly(Executive Officer)Geoff Race(Executive Officer)inFred Ahlholm(Executive Officer)inRLRemy Luthringer(Executive Officer, Director)Mark Levine(Executive Officer)

BoardMOMichele Ollier(Director)in

Co-investorsCACare CapitalINIndex VenturesLILifeSci Venture PartnersMEMedicxi

Olema is a clinical-stage biopharmaceutical company developing novel therapies for metastatic breast cancer and other endocrine-driven cancers, targeting nuclear receptors and mechanisms of acquired resistance.

BiotechHealthtechSan Francisco, US

Cyrus L. Harmon, Ph.D.(Director)CLCyrus L. Harmon(Director)inDavid C. Myles, Ph.D.(Executive Officer)Sean Bohen, M.D., Ph.D.(Executive Officer, Director)Naseem Zojwalla, M.D.(Executive Officer)inShane Kovacs(Executive Officer)in

Co-investorsAVAvoro Capital AdvisorsBABain Capital Life SciencesFOForesite CapitalLILightspeed Venture PartnersRARA CapitalWEWellington Management+2 more

Pasithea is a biotechnology company focused on the discovery and development of therapeutics for central nervous system disorders and RASopathies.

BiotechDeep TechHealthtechVenice, US

LSLawrence Steinman(Director)TRTiago Reis Marques(Chief Executive Officer)inIsrael Maxx Abramowitz(Executive Officer, Director)Craig Auringer(Executive Officer, Director)

Co-investorsJAJanus Henderson Investors

Passage Bio is a biotechnology company developing treatments for central nervous system (CNS) diseases, with a focus on neurodegenerative conditions.

BiotechHealthtechPhiladelphia, US

WCWilliam Chou(Chief Executive Officer)Tadataka Yamada(Executive Officer, Director, Promoter)SSStephen Squinto(Executive Officer, Director)in

BoardPHPatrick Heron(Director)inCGCarl Gordon(Director)inThomas Street Address 1 Woiwode(Director)

Co-investorsFRFrazier Life SciencesACAccess BiotechnologyFRFrazier Healthcare PartnersLILilly Asia VenturesNENew Leaf Venture PartnersOROrbiMed+2 more

Precision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).

BiotechDeep TechHealthtechDurham, US

MKMATTHEW KANE(Executive Officer, Director)JSJeff Smith(Co-founder)inDJDerek Jantz(Co-founder)inTODD MELBY(Executive Officer)inMAMichael Amoroso(President, Chief Executive Officer)in

BoardRAROBERT ADELMAN(Director)

Co-investorsAGage1AGAgent CapitalALAliment CapitalBRBrace PharmaF-F-Prime CapitalOCOCV Partners+6 more

Silence Therapeutics is a biotechnology company that discovers and develops short interfering RNA (siRNA) molecules designed to reduce the production of disease-associated proteins through the natural mechanism of RNA interference, with its proprietary mRNAi GOLD platform targeting specific genes in the liver for rare and common diseases.

BiotechLondon

Craig Tooman(Executive Officer)inGiles Campion(Executive Officer)Mark Rothera(Executive Officer, Director)inBarbara Ruskin(Executive Officer)

BoardJames Ede-Golightly(Director)Alistair Gray(Director)

Co-investorsFOForesite CapitalMCMC Healthcare VenturesNENextech Invest

Tarsus is a biopharmaceutical company focused on developing and delivering medicines that target the root cause of serious diseases with high unmet need, including eye conditions.

BiotechHealthtechMedical Devices

BABobak Azamian(Founder)inJeffrey Farrow(Chief Financial Officer and Chief Strategy Officer)Seshadri Neervannan(Chief Operating Officer)AMAziz Mottiwala(Chief Commercial Officer)inDWDianne Whitfield(Chief Human Resources Officer)inEYElizabeth Yeu-Lin(Chief Medical Officer)

Co-investorsAPAPERTURE Venture PartnersFLFlying L PartnersFRFrazier Life SciencesVIVisionary VenturesBABain Capital Life SciencesRTRTW Investments L.P.

Tenax Therapeutics is a clinical-stage pharmaceutical company developing TNX-103, an oral formulation of the drug levosimendan, to treat pulmonary hypertension resulting from heart failure with preserved ejection fraction (PH-HFpEF).

BiotechDigital HealthHealthtechChapel Hill, US

SRStuart Rich(Chief Medical Officer)LRLawrence R. Hoffman(Interim Chief Financial Officer)inMichael B. Jebsen(Executive Officer)CGChris Giordano(President and Chief Executive Officer)inDRDoug Randall(Chief Business Officer)inTSTom Staab(Chief Financial Officer)in

Zai Lab is a global biopharmaceutical company developing and commercializing therapies in oncology, immunology, neuroscience, and infectious disease, with operations in China and the United States.

BiotechHealthtechMedical Devices

S(Samantha (Ying) Du(Founder, Chief Executive Officer, Chairperson of the Board of Directors)inYCYajing Chen(Chief Financial Officer)inRGRafael G. Amado(President, Head of Global Research and Development)inFTF. Ty Edmondson(Chief Legal Officer)inJSJosh Smiley(President and Chief Operating Officer)Samantha Du(Founder)

Co-investorsQIQiming Venture PartnersYUYuanBio Venture CapitalADAdvantech CapitalHOHongShan Capital GroupKLKleiner PerkinsSESequoia Capital

Zenas BioPharma is a biopharmaceutical company developing therapies for autoimmune diseases, with two late-stage drug candidates: obexelimab, a bifunctional monoclonal antibody targeting CD19 and FcγRIIb to suppress B cell activity, and orelabrutinib, an oral BTK inhibitor.

BiotechHealthtechWaltham, US

LOLEON O. MOULDER, JR.(Director)LMLonnie Moulder(Founder)JOSEPH FARMER(Executive Officer)HMHUA MU(Executive Officer, Director)in

BoardPGPATRICK GERALD ENRIGHT(Director)inHONGBO LU(Director)

Co-investorsDEDelos CapitalLOLongitude CapitalNENew Enterprise Associates (NEA)NONorwest Venture PartnersPIPivotal Life SciencesQUQuan Capital+3 more

Ascendis Pharma is a biopharmaceutical company developing therapies for hormone-related disorders and rare diseases.

BiotechHealthtechMedical DevicesDenmark, DK

JMJan Møller Mikkelsen(Founder, President and Chief Executive Officer)inGrethe Rasmussen(Executive Officer)inHarald Rau(Executive Officer)Martin Olin(Director)Lotte S?nderbjerg(Executive Officer)MAMartin Auster(Executive Officer)in

Co-investorsAIAisling CapitalAVAvoro Capital AdvisorsFOForesite CapitalRARA CapitalSOSofinnova PartnersSOSofinnova Ventures

Esco Lifesciences manufactures laboratory equipment, biopharma devices, and IVF medical equipment for clinical, research, and industrial laboratories across more than 100 countries.

Advanced ManufacturingBiotechHardwareHealthtechMedical DevicesSingapore, SG

LLLim Lay Yew(Founder)inLow Yae Foong(Founder)

Co-investorsGIGICNONovo Holdings

Fortis Therapeutics develops therapeutic treatments based on technology licensed from UCSF, with a focus on oncology and other disease areas.

BiotechHealthtechMedical DevicesSan Diego, US

Marc Nasoff(Chief Scientific Officer)

BoardJBJay B. Lichter(Ph.D.)in

Co-investorsLILilly Asia VenturesAVAvalon BioVenturesOUOUP (Osage University Partners)

Gracell Biotechnologies develops cell therapy manufacturing platforms and treatments, with a focus on CAR-T cell therapies for cancer and autoimmune diseases.

BiotechHealthtechMedical DevicesSuzhou, CN

WWWilliam Wei Caoin

Co-investorsLALAVLILilly Asia VenturesOROrbiMedPIPivotal Life SciencesEXExome Asset ManagementJAJanus Henderson Investors+3 more

Inspirna is a clinical-stage biopharmaceutical company developing novel cancer drugs that target previously undruggable drivers of metastasis using its proprietary miRNA-DRIVEr platform.

BiotechHealthtechMedical DevicesNew York, US

Sohail Tavazoie(Co-Founder & Chair of Scientific Advisory Board)Masoud Tavazoie(Co-Founder & Advisor)in

Co-investorsSOSofinnova PartnersSASands Capital VenturesSTStart CapitalNONovo Holdings

Neocis develops Yomi, a robotic surgical platform that assists clinicians during dental implant surgery with planning, surgical, and restorative software features.

HealthtechMedical DevicesRoboticsMiami, US

AMAlon Mozes(Founder)inJSJuan Salcedo(Founder)inDMDennis Moses(Chief Technical Officer)inACAndres Carrillo(VP of Product)inJFJorge Fernandes(VP of Quality & Regulatory)inGGGabe Goldberg(VP of Marketing)in

Co-investorsINIntuitive VenturesNONorwest Venture PartnersCLCLI VenturesFLFlorida Opportunity FundMIMithril Capital ManagementNVNVIDIA+5 more

Oricell Therapeutics (原启生物) is a clinical-stage biopharmaceutical company developing cell therapies, including CAR-T products targeting GPRC5D for relapsed/refractory multiple myeloma and GPC3 for advanced liver cancer.

BiotechDeep TechHealthtechShanghai, CN

HYHelen Yang(Founder)inIHIris Huangin

Co-investorsQIQiming Venture PartnersQUQuan CapitalRTRTW Investments L.P.

ABK Biomedical is a clinical-stage medical device company that develops x-ray visible glass microspheres for Y-90 radioembolization and embolic treatment of cancers such as liver cancer.

BiotechHealthtechMedical DevicesHalifax, CA

RARobert Abraham(Co-founder (Interventional Radiologist, MD))inDBDaniel Boyd(Co-founder (Material Scientist))inSKSharon Kehoe(Co-founder (Material Scientist))inAHAnthony Headley(Executive Officer)inGDGary Donofrio(Executive Officer)inMMMichael Mangano(Executive Officer, Director)in

Board seatJoseph Siletto· per SEC Form D · $2.6M raise · filed Nov 2025

Co-investorsEIEight Roads VenturesF-F-Prime CapitalFIFirst Angel Network Association (FAN)

Aligos is a clinical-stage biotechnology company developing therapeutics for liver and viral diseases, including chronic hepatitis B virus (HBV) infection and MASLD/MASH.

BiotechHealthtechSouth San Francisco, US

Leonid Beigelman(President)inLMLawrence M. Blatt(Chairman, President, & Chief Executive Officer; co-founder)inHAHardean Achneck(Executive Officer)inBDBrian Dowd(Executive Vice President - Controller)inLucinda Quan(Executive Vice President - General Counsel)inJSJulian Symons(Executive Vice President, Chief Scientific Officer)in

Board seatJNJack Nielsen· per SEC Form D · $92.2M raise · filed Nov 2023

Co-investorsPIPivotal Life SciencesRORoche Venture FundWEWellington Management

BiotechSan Diego, US

FFFrancois Ferre(Director)MMMagda Marquet(Director)Jorge Garces(Executive Officer)inGreg Hamilton(Executive Officer, Director)Carin Sandvik(Executive Officer)Jeffrey G. Black(Executive Officer)

Board seatYuh-geng Tsay· per SEC Form D · $3M raise · filed Mar 2018

Co-investorsBIBioBritTETelegraph Hill PartnersALAlly Bridge GroupWUWuXi Healthcare Ventures

Amyris develops a biomanufacturing platform that uses fermentation and microbial engineering to produce natural ingredients and rare compounds at scale for partners across industries such as specialty chemicals, food ingredients, and consumer products.

Advanced ManufacturingBiotechCleantechNew MaterialsEmeryville, US

NICHOLAS KHADDER(Senior Vice President, General Counsel & Secretary)RARAFFI ASADORIAN(Chief Financial Officer)inJCJoel Cherry(President, Research & Development)inTTTamara Tompkins(Executive Vice President, General Counsel)inJMJohn Melo(President & Chief Executive Officer)inPDPaulo Diniz(Chief Financial Officer)in

Board seatFKFrank Kung· per SEC Form D

Co-investorsKLKleiner PerkinsMAMaple Leaf AngelsR7R7 Partners

Capnia offers the CoSense ETCOc Monitor, a non-invasive breath test that measures end-tidal carbon monoxide to detect and quantify hemolysis and bilirubin production in newborns.

Digital HealthHardwareHealthtechMedical DevicesRedwood City, US

Anthony E. Burgos(Co-Founder and President of Bilitool, Inc.)Gina Phelps(Executive Officer)David D. O'Toole(Executive Officer)Anish Bhatnagar(Executive Officer, Director)Anthony Wondka(Executive Officer)

BoardSteinar Engelsen(Director)

Board seatEGEdgar G. Engleman· per SEC Form D · $3.7M raise · filed Mar 2015

Co-investorsALAlliance VCALAlliance Venture

BiotechSanta Clara, US

Jeffrey Glenn(Director)David Cory(Executive Officer, Director)

BoardNKNina Kjellson(Director)inEd Engleman(Director)

Board seatEGEdgar G. Engleman· per SEC Form D · $3M raise · filed Apr 2016

Co-investorsPFPfizer Venture InvestmentsCACanaan PartnersVIVivo Ventures

Mediaspace is a digital agency that designs and builds custom Squarespace websites and provides SEO, digital marketing strategy, and digital advertising services.

AdTechAdvanced ManufacturingAI & Machine LearningData & InfrastructureDigital HealthEnterprise SoftwareHardwareHealthtechMarketing TechMedical DevicesSemiconductorsAtlanta, US

John G. Edwards(Executive Officer, Director)JJJohn Jacobi(Executive Officer)SPSri Peruvemba(Executive Officer)Francois Jeanneau(Executive Officer, Director)Linda Ara(Executive Officer)Michael Vestel(Executive Officer)

Board seatNathan DauJNJack Nielsen· per SEC Form D · $22M raise · filed Dec 2021

Co-investors3E3E Bioventures CapitalKEKeiretsu ForumLILife Sciences Greenhouse InvestmentsTOToba Capital

Readcoor developed an in situ spatial transcriptomics platform using padlock probe rolling circle amplification chemistry to detect and map RNA transcripts across tissue sections, now offered as the Xenium In Situ platform.

BiotechDeep TechHardwareHealthtechCambridge, US

Evan Daugharthy(Cofounder)Richard Terry(Executive Officer, Director)

BoardVictor Tong(Director)Thomas Grogan(Director)

Board seatYuh-geng Tsay· per SEC Form D

Co-investorsDEDecheng CapitalLALAVLILilly Asia VenturesLILilly VenturesPAPavilion Capital

Scientia Vascular develops guidewires, including the Aristotle and Zoom Wire product lines, for general vascular use within the neuro and peripheral vasculatures to introduce and position catheters and other interventional devices.

HealthtechMedical DevicesWest Valley City, US

John Lippert(Executive Officer, Director)Stacy Lippert(Executive Officer, Director)

BoardJeffrey Gladden(Dr. Gladden is a manager of the issuer.)David Bearss(Mr. Bearss is a manager of the issuer.)Rick Randall(Mr. Randall is a manager of the issuer.)Jerry Henley(Mr. Henley is a manager of the issuer.)

Board seatNathan DauJoseph Siletto· per SEC Form D

Co-investorsCOCowles Ventures

HealthtechIrvine, US

Kenny Chang(Executive Officer)W. Ronald Redmond(Director)Vijay Dhaka(Executive Officer)Philong Pham(Executive Officer, Director)Hongsheng Tong(Executive Officer, Director)

Board seatJoseph Siletto· per SEC Form D

Co-investorsBLBlackRockENEndeavour VisionMVMVM Life Science PartnersRTRTW Investments L.P.SOSoleus CapitalVEvenBio Global Strategic

35Pharma is a biopharmaceutical company developing biologics to treat diseases with high unmet medical need.

BiotechHealthtech

Ilia(CEO)Maureen(CSO)

Co-investorsFRFrazier Life SciencesVEvenBio PartnersJAJanus Henderson Investors

ADARx is a clinical-stage biotechnology company developing RNA-targeted therapeutics designed to control the expression of disease-driving genes.

BiotechHealthtechMedical DevicesSan Diego, US

ZLZhen Li(Co-founder, President & CEO)inRZRui Zhu(Founding Member & Chief Technology Officer)RARob Ackles(Chief People Officer)inRFRyan Fisk(Chief Financial Officer & Chief Business Officer)inRARobert A. MacLeod(Chief Scientific Officer)inCCChristopher Claeboe(Senior Vice President of Operations)in

Co-investorsBABain Capital Life SciencesOROrbiMedSRSR One Capital ManagementLILilly Asia VenturesT.T. Rowe PriceASAscenta Capital+4 more

ADAXION develops deimmunized biologic therapies using its ADAx platform, which incorporates proprietary CD22 ligands to eliminate therapeutic-specific B cells and reduce anti-drug antibody responses.

BiotechDeep Tech

Co-investorsJDJDRF T1D Fund

Adverum is a clinical-stage gene therapy company developing Ixo-vec, an investigational single-administration intravitreal treatment for wet age-related macular degeneration and other ocular diseases, based on a proprietary adeno-associated virus (AAV) vector platform.

BiotechDeep TechHealthtechRedwood City, US

Thomas W. Chalberg(Executive Officer, Director)Steven D. Schwartz(Director)Mark S. Blumenkranz(Director)Linda Rubinstein(Executive Officer)Setareh Seyedkazemi(Executive Officer)Kishor Peter Soparkar(Executive Officer)

Co-investorsAVAvoro Capital AdvisorsFRFrazier Life Sciences5A5AM VenturesSASamsara BioCapitalVEVenrock Healthcare Capital Partners

A medical device company developing orthopedic and biological solutions.

BiotechCleantechHardwareHealthtechMedical DevicesOhio, US

DKDavid Kirschman(Surgeon Inventor)in

Co-investorsASAsahi Kasei Corporate Venture CapitalHOHorizon Technology Finance

Agno Pharmaceuticals is a US-headquartered contract development and manufacturing organization (CDMO) that produces regulatory starting materials, intermediates, active pharmaceutical ingredients, and drug formulations for pharmaceutical and biotech companies.

Advanced ManufacturingBiotechHealthtechUnknown (US-headquartered stated, but specific city not provided), US

Ajax Therapeutics is a biotech company developing Type II JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPNs), including myelofibrosis, using computational chemistry and structural biology in its drug discovery.

AI & Machine LearningBiotechHealthtechNew York, US

Martin Vogelbaum(CEO, co-founder)inRoss Levine(Director)Ramy Farid(Director)

BoardScott Platshon(Director)

Co-investorsINInning One VenturesECEcoR1 CapitalRARA CapitalRERevelation Partners

Akira Bio develops therapies for people living with sickle cell disease and other hemoglobinopathies.

BiotechHealthtech

Co-investorsVEVersant VenturesMPMPM BioImpact

Attralus develops pan-amyloid removal (PAR) therapeutics — biologics and imaging agents designed to bind and remove toxic amyloid — to treat patients with systemic amyloidosis across all disease types and stages.

BiotechHealthtechSouth San Francisco, US

JWJonathan Wall(Executive Officer)inSpencer Guthrie(Executive Officer)MTMark Timney(Executive Officer, Director)inBenson Fong(Executive Officer)RKRahul Kakkar(Director)inGreg Bell(Executive Officer)

Co-investorsALAlpha Wave GlobalBIBioBritLILifeSci Venture PartnersVEvenBio PartnersJAJanus Henderson InvestorsREREDMILE+2 more

Co-investorsBABain Capital Life Sciences

BH Therapeutics is a drug development company that uses structure-based rational drug design to identify structural limitations in existing therapies and design novel chemical scaffolds to address them.

Biotech

JJJ. Jean Cui, Ph.D.(Scientific Founder, President and CEO)YPY. Peter Li, Ph.D., MBA(Cofounder and Executive Chairman)

Co-investorsOROrbiMed

BioDlink is a contract development and manufacturing organization (CDMO) providing drug development and manufacturing services for biopharmaceutical companies, with specialization in antibody-drug conjugates (ADCs).

Advanced ManufacturingBiotechEnterprise SoftwareHealthtechSuzhou, CN

Bonray Bio develops miniaturized microscopy optics and AI-powered image analysis software for reproductive medicine diagnostics, providing male infertility diagnostic instruments and consumables to fertility clinics globally.

AI & Machine LearningBiotechFemTechHealthtechMedical DevicesTaiwan, TW

Bonum Therapeutics develops antibody-controlled protein therapeutics that remain inactive until bound to their target, using a sensor-domain mechanism to deliver regulated, targeted activity.

BiotechHealthtechSeattle, US

JMJohn Mulligan(Executive Officer, Director, Promoter)inNPNeela Patel(Executive Officer)inDHDiane Hollenbaugh(Executive Officer)in

BoardSBSamuel Bjork(Director)inMSMonique Schiersing(Director)inJMJohn McKearn(Director)in

Co-investorsRIRiverVest Venture PartnersRORoche Venture Fund3X3x5 PartnersCOCodon CapitalDIDigitalis Ventures

Caidya provides clinical trial management solutions designed for pharmaceutical and biotech companies seeking to improve trial efficiency and patient outcomes through integrated, patient-centric approaches.

BiotechDigital HealthHealthtech

BLBarbara Lopez Kunz(Chief Executive Officer)inMCMichael Clay(Chief Operating Officer)inSMSharon Moore(Chief Medical Officer)inBPBrandon Pallott(Chief Commercial Officer)inMLMiron Lila(Chief Corporate Development Officer)inJSJohn Scott(Chief Information Officer)in

Co-investorsQIQiming Venture PartnersHAHatteras Venture Partners

Pharmaceutical company developing medicines and vaccines for patient health and treatment.

BiotechHealthtechSan Diego, US

JSJeffrey Stein(Executive Officer, Director)KJKevin Judice(Director)inKevin Forrest(Executive Officer)DTDirk Thye(Executive Officer)inKen Bartizal(Executive Officer)inPDPaul Daruwala(Executive Officer)in

Co-investors5A5AM VenturesAIAisling CapitalBABain Capital Life SciencesFRFrazier Life SciencesRARA CapitalCACanaan Partners+1 more

Clasp Therapeutics develops off-the-shelf precision T cell engagers (its proprietary pHLАre molecules) that target mutant peptide-HLA complexes displayed on cancer cells, directing T cells to destroy tumors carrying common driver mutations such as KRas.

BiotechHealthtechCambridge, US

Co-investorsCACatalio Capital Management, LPCUCure VenturesBRBrightEdgeCACatalio Capital ManagementNONovo HoldingsTHThird Rock Ventures

Lang Lai Technology (朗来科技) is a clinical-stage drug discovery company that runs an end-to-end new-drug R&D process spanning proof of concept, candidate compound screening, preclinical druggability development, and clinical research, pursuing both pipeline development and platform building.

BiotechHealthtechWuhan, CN

Co-investorsOROrbiMedLILilly Asia Ventures

Dutscher provides after-sales service (SAV) and post-delivery support (SAL) for laboratory equipment and consumables, handling warranty claims, non-warranty repairs, maintenance, product returns, and transport damage resolution.

Advanced ManufacturingB2B MarketplacesBiotechDeep TechE-commerceEnterprise SoftwareSaaS

Epibiologics develops protein degradation medicines using protein sciences and antibody engineering capabilities.

BiotechMedical DevicesSan Mateo, US

ALAnn Lee-Karlon(Executive Officer, Director)inMitchell Mutz(Executive Officer, Director)James Wells(Director)

BoardSBSamuel Bjork(Director)inACAlexandra Cantley(Director)inSMSeiji Miyahara(Director)in

Co-investorsAVAvego BioScience CapitalGVGV (Google Ventures)MIMission BiocapitalNONovartis Venture FundRORoche Venture FundSASamsara BioCapital+4 more

Esco Aster provides independent technical and investor due diligence services across biotechnology, pharmaceuticals, medical technology, and related life sciences sectors.

BiotechDeep TechFoodTechHealthtechImpact & Social GoodMedical DevicesSingapore, SG

XLXL Linin

Evaheart develops implantable and extracorporeal ventricular assist devices for heart failure and vascular disease treatment.

BiotechHardwareHealthtechMedical DevicesChongqing, CN

HanchorBio is a biotech company developing innovative immunotherapy drugs for cancer treatment through translational medicine, moving from early research to clinical applications.

BiotechHealthtechMedical DevicesTaiwan, TW

Co-investorsPAPanacea VentureKOKorea Investment Partners

HCmed Innovations develops inhaled drug delivery devices, including breath-actuated and continuous mode mesh nebulizers, along with connected mobile applications for monitoring treatment adherence.

HardwareHealthtechMedical Devices

HistoWiz offers histopathology services for cancer researchers, processing mailed tissue specimens and producing digital whole-slide images accessible through a cloud-based virtual microscope.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSaaSNew York City, US

KCKe Cheng(CEO)inLHLinh Hoang(Chief Executive Officer)inJKJerry Kuang(Chief Operations Officer)JFJulie Feldstein(Chief Pathologist)in

Co-investorsASAsahi Kasei Corporate Venture CapitalNENew York AngelsVEvenBio PartnersY Y CombinatorAVAvlok CapitalK5K5 Ventures+1 more

Clinical-stage genetic medicines company using human-derived AAV vectors and nuclease-free gene editing for rare diseases.

BiotechBedford, US

Siyamak Rasty(Executive Officer)Albert Seymour(Executive Officer)

BoardSteven Gillis(Director)ATArthur Tzianabos(Executive Officer, Director)KPKush Parmar(Director)inRichard Gregory(Director)

Co-investors5A5AM VenturesARARCH Venture PartnersOUOUP (Osage University Partners)ALAlexandriaDEDeerfield Management CompanyFIFidelity Investments+5 more

Immune Onc is a biotechnology company developing medicines to treat patients with hard-to-treat cancers and autoimmune diseases, with expertise in translational medicine and clinical development.

BiotechMedical DevicesPalo Alto, US

XCXiaoling Charlene Liao(Executive Officer, Director)Charlene Liao(Founder)in

BoardGuo-Liang Yu(Director)Liqun Luo(Director)

Co-investorsCLCLI VenturesNONorthern Light Venture CapitalSHShangBay Capital LLCSTStartXTRTriWise Capital

IOBiotech appears to be a biotech company focused on oncology, with a founder who has extensive experience in cancer drug development and clinical advancement from roles at Roche, Eli Lilly, and leading academic cancer centers.

BiotechMedical Devices

Dr. Dhingra

Co-investorsAVAvoro Capital AdvisorsEIEIR VenturesKUKurma PartnersPIPivotal Life SciencesRARA CapitalSASamsara BioCapital+3 more

Tebra provides an integrated electronic health record and medical billing platform for independent healthcare practices, including EHR tools, claims management, patient payments, and scheduling capabilities.

Digital HealthEnterprise SoftwareHealthtechSaaSIrvine, US

DANIEL RODRIGUES(Executive Officer, Director)JIM LIM(Director)PERRY WALLACK(Director)MICHAEL MATLY(Director)ROB REID(Director)DAVID COZZENS(Director)

Co-investorsESEscalate Capital PartnersGOGolub GrowthSASaints CapitalWEWestern Technology InvestmentGRGreenspring AssociatesHLHLM Investment Partners+4 more

Kinaset Therapeutics is a drug developer working on KN-002, a therapeutic candidate for treating severe asthma across patients regardless of the underlying cause of inflammation.

BiotechHealthtechMedfield, US

RHRoger Heerman(Chief Business/Operating Officer / Co-Founder)inFMFrazer Morgan(Chief Development Officer / Co-Founder)inRCRobert Clarke(Chief Executive Officer / Board Member / Co-Founder)Christopher O’Brien(Chief Medical Officer)

BoardJBJamil Beg(Director of the Issuer)inTom King(Director of the Issuer)

Co-investors5A5AM VenturesATAtlas VentureRARA CapitalEQEQT Life SciencesGIGimvSISixty Degree Capital+3 more

Kira Pharmaceuticals is a biotech company developing therapies targeting complement biology to treat complement-mediated diseases.

BiotechHealthtechCambridge, US

WSWenru Song(Founder)in

Co-investorsFOForesite CapitalQUQuan CapitalIKIkarian Capital

Lepu Biopharma is a Chinese biopharmaceutical company that develops antibody-drug conjugates (ADCs) and other oncology drugs, including the CD20-targeting ADC MRG001 for relapsed/refractory diffuse large B-cell lymphoma.

BiotechHealthtech

Medical devices company; acquired by LumiThera.

Co-investorsATATEL VenturesLILife Sciences Greenhouse Investments

Magnolia Medical develops diagnostic devices to reduce blood culture contamination and false-positive sepsis test results for hospitals and healthcare systems.

HardwareHealthtechMedical DevicesSeattle, US

Gregory J Bullington(Executive Officer, Director)RPRichard Patton(Co-founder)

BoardPaul Meister(Director)

Co-investorsEVEvidity Health CapitalLALauder PartnersMAMarram VenturesRHRhapsody Venture PartnersHEHealthQuest CapitalJAJanus Henderson Investors+3 more

Lite Strategy, Inc.

BiotechCrypto & Web3FintechHealthtechSan Diego, US

DMDavid M. Urso(Executive Officer)inDaniel P. Gold(Executive Officer, Director)BGBrian G. Drazba(Executive Officer)inMr. File(Chief Executive Officer & Board Member (former CFO))J(Justin (Jay) File(CEO, CFO)inKevan E. Clemens(Director)

Co-investors3B3B Future Health FundAIAisling CapitalGSGSRNENew Enterprise Associates (NEA)PRPrimitive VenturesAMAmzak Health+1 more

San Diego clinical-stage biopharma developing non-bile acid FXR agonists for liver and gastrointestinal diseases.

BiotechSan Diego, US

Ronald Evans(Director)Trisha Millican(Executive Officer)Ken Song(Executive Officer, Director)

BoardKBKristina Burow(Director)inRHRichard Heyman(Director)inANAmir Nashat(Director)in

Co-investorsAGage1ECEcoR1 CapitalLALAVLILifeSci Venture PartnersLILilly Asia VenturesNENew Enterprise Associates (NEA)+8 more

Neurogastrx is a biopharmaceutical company developing therapies for patients with gastrointestinal disorders.

BiotechHealthtechWoburn, US

CDCyril De Colle(Founder)inJAMES DETORE(Executive Officer)JOJAMES O'MARA(Executive Officer, Director)inPAUL ROGERS(Executive Officer)in

BoardDADAVID ALLISON(Director)inKVKLAUS VEITINGER(Director)in

Co-investors5A5AM VenturesOROrbiMedSASamsara BioCapitalVEvenBio PartnersRTRTW Investments L.P.VEvenBio Global Strategic+1 more

Ossium Health develops cellular therapies and bioengineered products for clinical use, leveraging adult stem cell technologies and advanced cell processing platforms.

BiotechHealthtechMedical DevicesSan Francisco, US

KCKevin Caldwell(Founder)inDr. Woods(Chief Science Officer, Co-Founder, EVP, CLIA Laboratory Director)SGSebastian Giwa(Director)inEWErik Woods(Founder)in

BoardWTWilliam Trenchard(Director)inThomas Cycyota(Director)

Co-investorsALAlumni VenturesFEFemHealth VenturesFIFirst Round CapitalGAGaingelsGEGeneral CatalystHEHemisphere Ventures LLC+5 more

BiotechChestnut Hill, US

JIJoseph Italiano(Director)inJonathan Thon(Director)Sven Erik Karlsson(Executive Officer)Peter Finn(Executive Officer)

Co-investorsBOBoston Harbor AngelsQIQiming HealthcareTHThird Rock Ventures

Poseida Therapeutics develops cell therapy candidates and related platform technologies for healthcare applications.

BiotechHealthtechSan Diego, US

EOEric Ostertag(Executive Officer, Director)MGMark Gergen(Executive Officer, Director)

BoardAdrian Howd(Director)David Hirsch(Director)

Co-investorsAIAisling CapitalLOLongitude CapitalRARapha Capital Management, LLC

HealthtechHouston, US

Jonathan P. Otterstatter(Executive Officer, Director)Larry Lawson(Executive Officer, Director)John Untereker(Executive Officer)

BoardWilliam Taranto(Director)Joseph Volpe(Director)

Co-investorsARArthur VenturesMEMerck Global Health Innovation FundNONovo HoldingsSASamsung Catalyst Fund

AgTechSanta Monica, US

FAFrances Arnold(Director)inPeter Meinhold(Executive Officer)inPCPedro Coelho(Executive Officer)inCHCorey Huck(Executive Officer, Director)in

BoardGKGANESH KISHORE(Director)inALAN BOYCE(Director)

Co-investorsALAliment CapitalKAKairos Venture Investments, LlcLALanx CapitalPOPontifax AgTechSPSpruce Capital PartnersXEXeraya Capital+1 more

Pulmocide is a biopharmaceutical company developing inhaled therapies for difficult-to-treat respiratory diseases, currently focused on respiratory fungal infections such as pulmonary aspergillosis.

BiotechHealthtech

PSPete Strong(Co-founder)Garth Rapeport(Co-founder)inKazuhiro Ito(Co-founder)inJohn Murray(Co-founder)inDMDavid Mantusin

Co-investorsADAdjuvant CapitalASAsahi Kasei Corporate Venture CapitalDEDementia Discovery FundF-F-Prime CapitalJEJeito CapitalLOLongwood Fund+4 more

RayzeBio develops radiopharmaceutical therapies for cancer treatment.

BiotechHealthtechMedical DevicesSan Diego, US

KSKen Song(Executive Officer, Director)inBHBen Hickey(President)inAbhi Bhat, PhD(Senior Vice President, Research & Development)Deborah Charych(Executive Officer)Yi Larson(Director)

BoardARAaron Royston(Director)in

Co-investorsLILifeSci Venture PartnersSASamsara BioCapitalSCScion Life SciencesSOSofinnova VenturesTCTCG CrossoverVEvenBio Partners+4 more

Regulus is a Japanese company working on recruiting automation software.

Future of WorkHR Tech

Max Koenig

Co-investors50500 GlobalSISierra VenturesCACanaan Partners IsraelF2F2 Venture CapitalNENew Enterprise Associates (NEA)RARA Capital

RemeGen is a biopharmaceutical company that develops and commercializes innovative biologic drugs, including telitacicept (a dual-target BLyS/APRIL biologic for systemic lupus erythematosus) and disitamab vedotin (a HER2-targeting antibody-drug conjugate for cancers such as urothelial carcinoma).

BiotechHealthtechYantai, CN

Wang Weidong(Co-founder)Jianmin Fang(Co-founder & CEO)

Co-investorsAPApricot Capital

Rgenta develops orally available small molecule therapies that target RNA to address diseases previously considered undruggable, with programs in oncology (targeting proteins such as MYB in solid tumors and hematologic cancers) and central nervous system repeat expansion disorders like Huntington's disease.

AI & Machine LearningBiotechDeep TechHealthtechCambridge, US

TWTravis Wager(Co-founder, President and CSO)inHualin Simon Xi(Executive Officer, Director)ZWZhiping Weng(Co-founder)inSXSimon Xi(Co-founder and CEO)inJWJackie Walling(CMO)Debasish Roychowdhury(Director)

Co-investorsDEDelos CapitalAMAMR Action FundBOBoehringer Ingelheim Venture FundKOKorea Investment PartnersLILilly Asia VenturesMAMatrix Capital Management+1 more

Ronovo Surgical develops the Carina surgical robotics platform, including a vision system and instruments, for use by surgeons and hospitals.

HealthtechMedical DevicesRoboticsShanghai, CN

JMJohn Ma(Founder)inYing Mao(Founder)in

Co-investorsGRGranite AsiaININCE CapitalJJJJDCLILilly Asia Ventures

SanegeneBio is a biotech company developing RNA interference (RNAi) genetic medicines for obesity, cardiometabolic, and autoimmune diseases.

BiotechDeep TechLongevityBoston, US

SWShiyu Wang(Founder)inWeimin Wang(Founder)Weimin Wang, Ph.D.(Founder, Chief Executive Officer)Shiyu Wang, Ph.D.(Co-Founder, Chief Scientific Officer)

Co-investorsQIQiming Venture Partners

Satsuma Pharmaceuticals develops therapeutics for the acute treatment of migraine, including an approved dihydroergotamine nasal powder product (Atzumi/STS101).

BiotechHealthtechMedical DevicesSouth San Francisco, US

JKJohn Kollins(Executive Officer, Director)Tadayoshi Iwashima(Executive Officer)TBThomas B. King(President and Board Director)inRJRob Janosky(Chief Commercial Officer)TOTom O'Neil(Chief Financial Officer)inDavid Prichard(Chief Operating Officer)

Co-investorsOUOUP (Osage University Partners)WEWellington ManagementLULumira VenturesRARA CapitalRERed Tree VentureSBSBI Investment

SentreHeart appears to now redirect to AtriCure, Inc., a medical device company.

BiotechHardwareHealthtechMedical DevicesRedwood City, US

RSRussell Seiber(Executive Officer, Director)inPSPam Simons(Executive Officer)inGreg Fung(Executive Officer)RSRobert Strasser(Executive Officer)in

BoardPYPhil Young(Director)inVictor Tong(Director)

Co-investorsDEDecheng CapitalPRProspect Venture PartnersUSUS Venture PartnersDEDeerfield Management CompanyU.U.S. Venture Partners

Serán is a contract development and manufacturing organization (CDMO) that provides drug formulation, development, and manufacturing services to pharmaceutical companies.

Advanced ManufacturingBiotechDeep TechHealthtechMedical Devices

DSDan Smithey(President & CEO, Co-founder)in

Serapha Bio is a biotechnology company.

Biotech

Co-investorsRARA CapitalRTRTW Investments L.P.

A biopharmaceutical company that discovers, develops, and delivers medicines and vaccines, with research and development across respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.

BiotechHealthtechMedical DevicesSan Francisco, US

Co-investorsCACapital Midwest FundFRFrazier Life SciencesLOLongitude CapitalRARA CapitalOXOxford Finance LLC

SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound-mediated delivery) to deliver genetic payloads to targeted sites in a redosable way.

BiotechDeep TechDigital HealthHealthtechSouth San Francisco, US

KGKenneth Greenberg(Co-Founder, President & CEO)in

Co-investorsVIVida VenturesLELeaps by BayerARARCH Venture PartnersFOFoothill VenturesILIllumina VenturesMEMedical Excellence Capital+8 more

Tebra provides an all-in-one operating system for independent healthcare practices, combining EHR, medical billing, patient payments, and practice management tools.

Digital HealthEnterprise SoftwareHealthtechSaaSCorona Del Mar, US

Co-investorsGOGolub GrowthHLHLM Investment PartnersTOToba Capital

Terns Pharmaceuticals is a biopharmaceutical company developing therapies, including its TERN-701 program.

BiotechHealthtechFoster City, US

Mark Vignola, Ph.D.(Executive Officer)Bryan Yoon(Executive Officer)inSSSenthil Sundaram(Director, Executive Officer)inWeidong Zhong, Ph.D.(Executive Officer, Director)JQJill Quigley(Director)inDavid Fellows(Director)

Co-investorsDEDecheng CapitalLALAVLILilly Asia Ventures

Theranica develops non-invasive, drug-free wearable therapeutic devices for pain treatment, combining neuroscience research with mobile digital technology.

Digital HealthHealthtechMedical Devices

AIAlon Ironi(Founder)in

Co-investorsLILionBirdAMaMoonLILightspeed Venture Partners

Biotechnology company developing cellular therapies for organ transplantation and autoimmune disorders.

Co-investorsANAnjostAVAvego BioScience CapitalAVAvoro Capital AdvisorsLOLongitude CapitalSCScion Life SciencesTCTCG Crossover+1 more

Tria develops handheld laser devices for at-home hair removal and skincare, using laser technology similar to that used in professional clinics.

ConsumerDirect to ConsumerHardwareHealthtechWellness & FitnessDublin, US

TCTOBIN C. ISLAND(Executive Officer)inKJKEVIN J. APPELBAUM(Executive Officer, Director)inDYDEREK YUNG(Executive Officer)inDHDANIKA HARRISON(Executive Officer)inJIYOUNG CHOI(Executive Officer)CHARLES BRACHER(Director)in

Co-investorsAIAisling CapitalBABay City CapitalINIncubic Management LLC

Verona Pharma develops treatments for chronic lung conditions.

BiotechHealthtechLondon

Jan-Anders Karlsson(Executive Officer, Director)inPSPeter Spargo(Executive Officer)inPatrick Humphrey(Director)Ken Cunningham(Director)Kenneth Newman(Executive Officer)Anders Ullman(Director)

Co-investorsACAccess BiotechnologyAIAisling CapitalANAndera PartnersFOForesite CapitalFRFrazier Life SciencesNENew Enterprise Associates (NEA)+4 more

VISEN Pharmaceuticals is a biopharmaceutical company focused on endocrine-related therapies, developing and commercializing treatments such as long-acting growth hormone and parathyroid hormone therapies.

BiotechDigital HealthHealthtechShanghai, CN

Co-investorsSOSofinnova Ventures

WuXi AppTec is a global Contract Research, Development and Manufacturing Organization (CRDMO) that provides integrated drug development services spanning chemistry, biology discovery, preclinical testing, and clinical research across Asia, Europe, and North America.

Advanced ManufacturingBiotechEnterprise SoftwareHealthtech

Ge Li(Founder)

Co-investorsHIHighlight CapitalHOHongShan Capital GroupHUHuangpu River CapitalLELegend Capital

Zai is an Australian fintech payments provider that offers an integrated platform for processing multiple payment methods including credit cards, direct debits, and account-to-account transfers.

Enterprise SoftwareFintechSaaSMelbourne, AU

Co-investorsFRFrontline VenturesOCOctopus VenturesRARampersandREReinventure GroupSCSC VenturesCUCultivation Capital+2 more